Ceruvin-A 15 Capsules

babies: it does not apply to babies. lactating mothers: needs to seek doctor’s advice. pregnancy: needs to seek doctor’s advice.
aspirin & clopidogrel bisulfate capsule is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. driving: aspirin & clopidogrel bisulfate capsules may decrease alertness, affect your vision or make you feel sleepy and dizzy. do not drive if these symptoms occur. alcohol: aspirin & clopidogrel bisulfate capsules may cause excessive drowsiness with alcohol. kidney: aspirin & clopidogrel bisulfate capsules should be used with caution in patients with severe kidney disease.
you may require dose adjustment of aspirin & clopidogrel bisulfate capsule. please consult your doctor.
regular monitoring of blood pressure is advisable for dose adjustment. liver: aspirin & clopidogrel bisulfate capsules should be used with caution in patients with liver disease. you may require dose adjustment of aspirin & clopidogrel bisulfate capsule.
please consult your doctor..

Abdominal pain Bruise Diarrhoea Gastrointestinal bleeding Increased bleeding tendency Nosebleeds.

CERUVIN A capsule is a combination of two antiplatelet medicines: which helps prevent heart attack. they work by preventing the platelets from sticking together and decrease the formation of harmful blood clots..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• you have been prescribed CERUVIN A capsule lower your risk of heart attack and stroke. • take it with food to avoid an upset stomach. • it increases your risk of bleeding.
be careful while shaving, cutting fingernails or toenails or using sharp objects. • let your doctor know you are taking aspirin & clopidogrel bisulfate capsule before undergoing any surgical procedure..

contraindicated • defibrotide + aspirin: concurrent use may result in an increased risk of bleeding • defibrotide + clopidogrel: concurrent use may result in an increased risk of bleeding serious • nsaids + aspirin: concurrent use may result in an increased risk of bleeding and increased risk of cardiovascular events • amlodipine + clopidogrel: concurrent may result in decreased antiplatelet effect and increased risk of thrombotic events. closely monitor • prednisolone + aspirin: concurrent use may result in an increased risk of gastrointestinal ulceration.